Dr. Roslyn Thelingwani

  • A preclinical Drug Metabolism and Pharmacokinetics (DMPK) scientist with research focus in the area of antiparasitic drugs and neglected diseases with more than 10 years’ experience.

  • Obtained a bachelor’s in Biochemistry and a master’s degree in Biotechnology from the University of Zimbabwe. She then received her PhD from the University of Cape Town, South Africa.

  • Besides her research, Roslyn has supported many clinical trials and preclinical projects with bioanalysis on either the HPLC or mass spectrometer.

  • She led a team that set-up the first DNA testing centre in Zimbabwe at the African Institute of Biomedical Science and Technology.

  • Other notable achievements include the set- up of the state-of-the-art bioanalytical laboratory and ADME toolkit for screening new drug candidates for safety and ADME liabilities, again the first of its kind in Zimbabwe.

  • Roslyn is a recipient of the Global Health and Equity Scholars fellowship where she received a grant to support her research on the safety and efficacy of praziquantel when co-administered with antiretroviral drugs, and the implications on mass drug administration programs. She also received a supporting grant from The World Academy of Sciences (TWAS) for the same study.